Zealand Pharma A/S Ord (ZLDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 977,288 | -156,430 | -102,183 | -170,222 | -161,988 |
| Depreciation Amortization | 4,144 | 3,748 | 3,643 | 16,703 | 6,404 |
| Accounts receivable | -13,363 | -7,099 | -981 | 2,580 | -10,261 |
| Accounts payable and accrued liabilities | -27,000 | 13,038 | 5,784 | -8,305 | -7,805 |
| Other Working Capital | -55,084 | 17,745 | 7,565 | 1,453 | -26,462 |
| Other Operating Activity | 102,950 | -5,969 | 24,365 | 24,374 | 7,288 |
| Operating Cash Flow | $988,935 | $-134,968 | $-61,807 | $-133,417 | $-192,825 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -333,543 | -1,061,366 | -155,405 | 26,420 | 638 |
| PPE Investments | -1,475 | -1,458 | -1,632 | -1,658 | -3,521 |
| Purchase Sale Intangibles | -5,406 | -449 | -1,816 | N/A | N/A |
| Other Investing Activity | -5,406 | -449 | -1,816 | 15,064 | 0 |
| Investing Cash Flow | $-340,424 | $-1,063,273 | $-158,854 | $39,826 | $-2,883 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 53,631 | N/A | N/A | 103,082 |
| Common Stock Issued | 7,441 | 1,235,904 | 227,086 | 153,588 | 123,310 |
| Common Stock Repurchased | -61,646 | -51,016 | -6,040 | N/A | -4,549 |
| Other Financing Activity | -3,053 | -36,688 | -89,347 | -70,412 | -9,802 |
| Financing Cash Flow | $-57,257 | $1,201,831 | $131,698 | $83,176 | $212,041 |
| Exchange Rate Effect | -8,287 | 904 | -1,051 | 1,938 | 10,536 |
| Beginning Cash Position | 109,921 | 65,150 | 155,253 | 159,881 | 152,771 |
| End Cash Position | 692,888 | 69,644 | 65,240 | 151,404 | 179,640 |
| Net Cash Flow | $582,967 | $4,494 | $-90,013 | $-8,478 | $26,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | 988,935 | -134,968 | -61,807 | -133,417 | -192,825 |
| Capital Expenditure | -5,052 | -1,458 | -1,632 | -1,658 | -3,521 |
| Free Cash Flow | 983,883 | -136,426 | -63,439 | -135,075 | -196,346 |